ENSC
Price
$2.13
Change
-$0.02 (-0.93%)
Updated
Sep 5 closing price
Capitalization
6.34M
GNPX
Price
$0.23
Change
+$0.07 (+43.75%)
Updated
Sep 5 closing price
Capitalization
7.68M
Interact to see
Advertisement

ENSC vs GNPX

Header iconENSC vs GNPX Comparison
Open Charts ENSC vs GNPXBanner chart's image
Ensysce Biosciences
Price$2.13
Change-$0.02 (-0.93%)
Volume$30.13K
Capitalization6.34M
Genprex
Price$0.23
Change+$0.07 (+43.75%)
Volume$129.31M
Capitalization7.68M
ENSC vs GNPX Comparison Chart in %
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENSC vs. GNPX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and GNPX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ENSC: $2.13 vs. GNPX: $0.23)
Brand notoriety: ENSC and GNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 7% vs. GNPX: 1958%
Market capitalization -- ENSC: $6.34M vs. GNPX: $7.68M
ENSC [@Biotechnology] is valued at $6.34M. GNPX’s [@Biotechnology] market capitalization is $7.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileGNPX’s FA Score has 0 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • GNPX’s FA Score: 0 green, 5 red.
According to our system of comparison, GNPX is a better buy in the long-term than ENSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 3 TA indicator(s) are bullish while GNPX’s TA Score has 5 bullish TA indicator(s).

  • ENSC’s TA Score: 3 bullish, 5 bearish.
  • GNPX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GNPX is a better buy in the short-term than ENSC.

Price Growth

ENSC (@Biotechnology) experienced а +2.15% price change this week, while GNPX (@Biotechnology) price change was +39.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNPX($7.68M) has a higher market cap than ENSC($6.34M). GNPX has higher P/E ratio than ENSC: GNPX (0.27) vs ENSC (0.02). GNPX (-73.051) and ENSC (-73.771) have similar YTD gains . ENSC has higher annual earnings (EBITDA): -6.56M vs. GNPX (-17.31M). ENSC has more cash in the bank: 2.21M vs. GNPX (1.35M). GNPX has less debt than ENSC: GNPX (279K) vs ENSC (425K). ENSC (0) and GNPX (0) have equivalent revenues.
ENSCGNPXENSC / GNPX
Capitalization6.34M7.68M83%
EBITDA-6.56M-17.31M38%
Gain YTD-73.771-73.051101%
P/E Ratio0.020.277%
Revenue00-
Total Cash2.21M1.35M164%
Total Debt425K279K152%
FUNDAMENTALS RATINGS
ENSC vs GNPX: Fundamental Ratings
ENSC
GNPX
OUTLOOK RATING
1..100
6029
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8896
P/E GROWTH RATING
1..100
7838
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSC's Valuation (23) in the null industry is in the same range as GNPX (45) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

ENSC's Profit vs Risk Rating (100) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

ENSC's SMR Rating (100) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

ENSC's Price Growth Rating (88) in the null industry is in the same range as GNPX (96) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

GNPX's P/E Growth Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for ENSC (78) in the null industry. This means that GNPX’s stock grew somewhat faster than ENSC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSCGNPX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WNW1.860.02
+1.09%
Meiwu Technology Company Limited
PPBI24.49N/A
N/A
Pacific Premier Bancorp
APG34.96-0.06
-0.17%
APi Group Corporation
CRDL1.09-0.02
-1.80%
Cardiol Therapeutics
RAPP14.36-0.99
-6.45%
Rapport Therapeutics Inc.

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-0.70%
MLLCF - ENSC
40%
Loosely correlated
N/A
SNSE - ENSC
29%
Poorly correlated
-5.60%
HOWL - ENSC
29%
Poorly correlated
N/A
GNPX - ENSC
27%
Poorly correlated
+47.40%
HNSBF - ENSC
25%
Poorly correlated
N/A
More

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with HURA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
+47.40%
HURA - GNPX
60%
Loosely correlated
+0.79%
REVB - GNPX
48%
Loosely correlated
+2.50%
HOWL - GNPX
42%
Loosely correlated
N/A
APVO - GNPX
34%
Loosely correlated
-1.23%
TYRA - GNPX
33%
Poorly correlated
+4.20%
More